Misoprostol used in combination of estrogen after menopause to take part.doc

 PAGE \* MERGEFORMAT 32 Misoprostol used in combination of estrogen after menopause to take part Author: Kai-Hung Lu Yan Xuemei Dong Jing 【Key Words】 papers take part with post-menopausal estrogen tablets misoprostol tablets 【Abstract】 Objective: To study the success rate of postmenopausal women to take part in an effective manner. Methods: 144 cases of post-menopausal women were randomly asked to take part into conjugated estrogen group, misoprostol group and the combination of estrogen and misoprostol compatibility group (compatibility group) of 48 cases. Three groups in age, with ring time, there was no statistical difference in post-menopausal time, with comparable (Pgt; 0.05). Preoperative combined estrogen-3 days of oral conjugated estrogen tablets 1.25 ㎎, a time / day. 3h preoperative misoprostol sublingual misoprostol tablets 400μg. Compatibility group of patients 3 days before oral conjugated estrogen tablets 1.25 ㎎ 1 times / day, the first 4 days of preoperative 3h sublingual misoprostol tablets 400μg. Observed three groups of patients in the cervical dilatation and pain response, a success rate of intrauterine devices and drug side effects. Results: The intraoperative cervical dilatation and efficient combination of estrogen group was 79.17%, misoprostol group was 87.5%, compatibility group 100% (P lt;0.05). Analgesic effect in order to compatibility group was pain-free rate of 87.50%, but the compatibility group and the misoprostol group, difference was not statistically significant. The success rate of intrauterine estrogen group to take part with a smooth 35.42%, 50% difficult to take part, take part failures 14.58%; misoprostol group to take part successfully 75% of the ring difficult to take 20.83%, 4.17% failed to take part; compatibility group to take Central smoothly 95.83%, 4.17% difficult to take part. Drug side effects: misoprostol group and the compatibility group of 6 patients with mild nausea and diarrhea. Conclusion: The